Company Description
Medarex is building the ultimate monoclonal antibody. Its UltiMAb technology utilizes transgenic mice whose antibody gene...
Key Medarex Financials
| Company Type | Public - NASDAQ (GM): MEDX Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $56.3 |
| 2007 Employees | 500 |
More Medarex Financials (11 pages)
Latest Medarex Jobs jobs by Indeed
Competition
Competitive Landscape for Biotechnology Sector
Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is...
Read more about Medarex's competition across multiple industries
Top Medarex Competitors
Sponsored Links
The Business DirectoryMedarex Executives
| Title | Name & Bio | Contact |
|---|---|---|
| Honorary Chairman Emeritus | Irwin Lerner | Network | E-mail |
| SVP Finance and Administration and CFO | Christian S. Schade | Network | E-mail |
| SVP Business Development | Ronald A. Pepin | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Current Medarex News
- BioWorld Today October 8, 2008 [BioWorld Today] (08 Oct 2008 00:01:00 EDT)
- Medarex, Inc. (MEDX) Corporate Event Announcement Notice [Wall Street Horizon] (07 Oct 2008 21:14:00 EDT)
- Medarex, Inc. (MEDX) Corporate Event Announcement Notice [Wall Street Horizon] (04 Oct 2008 20:50:00 EDT)
Sponsored Opportunity






